The emergence of another tickborne infection in the 12-town area around Lyme, Connecticut: Human granulocytic ehrlichiosis

Journal of Infectious Diseases

Volumn 181, Issue 4, 2000, Pages 1388-1393

  IJdo, Jacob W ^a   Meek, James I ^a   Cartter, Matthew L ^c   Magnarelli, Louis A ^b   Wu, Caiyun ^a   Tenuta, Suzanne W ^a   Fikrig, Erol ^a   Ryder, Robert W ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Connecticut Agric Exp Station ^*  (United States)

^c CDC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASMA PHAGOCYTOPHILUM; ARTICLE; EHRLICHIOSIS; HUMAN; INFECTION RISK; LYME DISEASE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TICK; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES, BACTERIAL; CHILD; CHILD, PRESCHOOL; CONNECTICUT; EHRLICHIA; EHRLICHIOSIS; FEMALE; FEVER; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; INSECT VECTORS; IXODES; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES;

EID: 0012842925     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315389     Document Type: Article

References (27)

1. 1. Dumler JS, Bakken JS. Human ehrlichioses: newly recognized infections transmitted by ticks. Annu Rev Med 1998; 49:201-13.
2. 2. Pancholi P, Kolbert CP, Mitchell PD, et al. Ixodes dammini as a potential vector of human granulocytic ehrlichiosis. J Infect Dis 1995; 172:1007-12.
3. 3. Telford SRI, Dawson JE, Katavolos P, Warner CK, Kolbert CP, Persing DH. Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle. Proc Natl Acad Sci USA 1996; 93:6209-14.
4. 4. Magnarelli LA, Dumler JS, Anderson JF, Johnson RC, Fikrig E. Coexistence of antibodies to tick-borne pathogens of babesiosis, ehrlichiosis, and Lyme borreliosis in human sera. J Clin Microbiol 1995; 33:3054-7.
5. 5. Nadelman RB, Horowitz HW, Hsieh TC, et al. Simultaneous human granulocytic ehrlichiosis and Lyme borreliosis. N Engl J Med 1997; 337:27-30.
6. 6. Krause PJ. Spielman AS, Telford SR, et al. Persistent parasitemia after acute babesiosis. N Engl J Med 1998; 339:160-5.
7. 7. Magnarelli LA, IJdo JW, Anderson JF, Padula SJ, Flavell RA, Fikrig E. Human exposure to a granulocytic ehrlichia and other tick-borne agents in Connecticut. J Clin Microbiol 1998; 36:2823-7.
8. 8. Bakken JS, Dumler JS, Chen SM, Eckman MR, Van Etta LL, Walker DH. Human granulocytic ehrlichiosis in the upper midwest United States: a new species emerging? JAMA 1994; 272:212-8.
9. 9. IJdo JW, Zhang Y, Hodzic E, et al. The early humoral response in human granulocytic ehrlichiosis. J Infect Dis 1997; 176:687-92.
10. 10. Centers for Disease Control and Prevention. Lyme disease - United States, 1996. MMWR Morb Mortal Wkly Rep 1997; 46:531-5.
11. 11. Guarino PD, Meek JI, Kusha B, et al. Statewide surveillance for ehrlichiosis - Connecticut and New York, 1994-1997. MMWR Morb Mortal Wkly Rep 1998; 479:476-80.
12. 12. Meek JI, Roberts CL, Smith EV, Cartter ML. Underreporting of Lyme disease by Connecticut physicians, 1992. J Public Health Manag Pract 1996; 2:61-5.
13. 13. Lederberg J, Shope RE, Oaks SC, eds. Emerging infections: microbial threats to health in the United States. Washington, DC: National Academy Press, 1992.
14. 14. Steere AC, Broderick TF, Malawista SE. Erythema chronicum migrans and Lyme arthritis: epidemiologic evidence for a tick vector. Am J Epidemiol 1978; 108:312-21.
15. 15. Connecticut Department of Public Health. Lyme disease in Connecticut, 1996. Conn Epidemiol 1997; 17:17-8.
16. 16. Magnarelli LA, Stafford KC, Mather TN, Yeh MT, Horn KD, Dumler JS. Hemocytic rickettsia-like organisms in ticks: serologic reactivity with antisera to ehrlichiae and detection of DNA of agent of human granulocytic ehrlichiosis by PCR. J Clin Microbiol 1995; 33:2710-4.
17. 17. Stafford KC III, Cartter ML, Magnarelli LA, Ertel SH, Mshar PA. Temporal correlations between tick abundance and prevalence of ticks infected with B. burgdorferi and increasing incidence of Lyme disease. J Clin Microbiol 1998; 36:1240-4.
18. 18. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Morb Mortal Wkly Rep 1997; 46:46-7.
19. 19. Hodzic E, Fish D, Maretzki CM, De Silva A, Feng S, Barthold SW. Acquisition and transmission of the agent of human granulocytic ehrlichiosis by Ixodes scapularis ticks. J Clin Microbiol 1998; 36:3574-8.
20. 20. IJdo JW, Sun W, Zhang Y, Magnarelli LA, Fikrig E. Cloning of the gene encoding the 44-kilodalton antigen of the agent of human granulocytic ehrlichiosis and characterization of the humoral response. Infect Immun 1998; 66:3264-9.
21. 21. Magnarelli LA, IJdo JW, Stafford KC, Fikrig E. Granulocytic ehrlichia and Borrelia burgdorferi infections in deer in Connecticut. J Wildl Dis 1999; 35:266-79.
22. 22. Dean AG, Dean JA, Coulombier D, et al. Epi Info, version 6: a word processing, database, and statistical program for public health on IBM compatible microcomputers. Atlanta: Centers for Disease Control and Prevention, 1995.
23. 23. Bakken JS, Krueth J, Wilson-Nordskog C, Tilden RL, Asanovich K, Dumler JS. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA 1996; 275:199-205.
24. 24. Bakken JS, Goellner P, Van Etten M, et al. Seroprevalence of human granulocytic ehrlichiosis among permanent residents of northwestern Wisconsin. Clin Infect Dis 1998; 27:1491-9.
25. 25. Dumler JS, Bakken JS. Human granulocytic ehrlichiosis in Wisconsin and Minnesota: a frequent infection with the potential for persistence. J Infect Dis 1996; 173:1027-30.
26. 26. Ravyn MD, Goodman JL, Kodner CB, et al. Immunodiagnosis of human granulocytic ehrlichiosis by using culture-derived human isolates. J Clin Microbiol 1998; 36:1480-8.
27. 27. IJdo JW, Wu C, Magnarelli LA, Fikrig E. Serodiagnosis of human granulocytic ehrlichiosis by a recombinant HGE-44-based enzyme-linked immunosorbent assay. J Clin Microbiol 1999; 37:3540-4.